Axon Enterprise, Inc. (NASDAQ:AXON) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Axon Enterprise, Inc. (NASDAQ:AXONGet Free Report) have received a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $604.67.

Several research firms recently commented on AXON. Robert W. Baird raised their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Needham & Company LLC reiterated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a report on Wednesday, February 26th. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Barclays reaffirmed a “hold” rating on shares of Axon Enterprise in a research note on Monday, March 10th. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a research report on Tuesday, December 3rd.

Check Out Our Latest Stock Report on AXON

Insider Buying and Selling

In other Axon Enterprise news, insider Jeffrey C. Kunins sold 1,035 shares of the firm’s stock in a transaction on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total value of $646,326.45. Following the sale, the insider now directly owns 124,243 shares in the company, valued at $77,586,026.21. This trade represents a 0.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jeri Williams sold 307 shares of the company’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 1,792 shares of company stock valued at $1,087,843. Insiders own 5.70% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AXON. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $30,000. Prestige Wealth Management Group LLC lifted its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after purchasing an additional 44 shares in the last quarter. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter valued at approximately $41,000. Finally, Y.D. More Investments Ltd bought a new position in shares of Axon Enterprise in the fourth quarter valued at $45,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Trading Down 1.7 %

Shares of NASDAQ AXON opened at $558.41 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise has a one year low of $273.52 and a one year high of $715.99. The business has a 50-day moving average price of $592.10 and a two-hundred day moving average price of $539.60. The firm has a market capitalization of $42.79 billion, a PE ratio of 144.29, a PEG ratio of 5.17 and a beta of 1.12.

Axon Enterprise Company Profile

(Get Free Report

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Further Reading

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.